Net profit of Medicamen Biotech declined 46.01% to Rs 2.03 crore in the quarter ended December 2023 as against Rs 3.76 crore during the previous quarter ended December 2022. Sales rose 30.69% to Rs 46.50 crore in the quarter ended December 2023 as against Rs 35.58 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales46.5035.58 31 OPM %10.5216.53 - PBDT5.085.82 -13 PBT3.274.22 -23 NP2.033.76 -46 Powered by Capital Market - Live News

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 12 February 2024.Powered by Capital Market - Live News

Net profit of Medicamen Biotech declined 58.06% to Rs 1.51 crore in the quarter ended September 2023 as against Rs 3.60 crore during the previous quarter ended September 2022. Sales rose 29.85% to Rs 43.54 crore in the quarter ended September 2023 as against Rs 33.53 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales43.5433.53 30 OPM %10.6617.45 - PBDT4.295.76 -26 PBT2.464.14 -41 NP1.513.60 -58 Powered by Capital Market - Live News

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 10 November 2023.Powered by Capital Market - Live News

Medicamen Biotech announced that the 30th Annual General Meeting (AGM) of the company will be held on 27 September 2023.Powered by Capital Market - Live News